Biohaven Ltd (BHVN) Total Business Assets

Graphic logo of Biohaven Pharmaceutical (BHVN)

Biohaven Ltd. (BHVN) is an innovative biotech company developing patented small molecules to treat migraines and nervous system pathologies. Business stability is underpinned by robust intellectual property and a promising pipeline of drugs under development. This chart of total asset price action, which currently stands at 460.59, complements data on the performance of Vlad Korich's team, which is effectively expanding the R&D portfolio with the support of loyal shareholders.

Biohaven Ltd. (BHVN): Cumulative Company Assets from 07/04/2022 to 10/28/2026

Analytical breakdowns for Biohaven Pharmaceutical (BHVN)

- price and consensus price forecast:
Share Price biohavenpharma.com|BHVN - Price Target Chart
- market capitalization data:
Market Capitalization Biohaven Corp|BHVN - Enterprise Value
- book capitalization data:
Net Asset Value per Share Biohaven|BHVN - Company Net Assets|Market Capitalization to Book Value Ratio biohavenpharma.com|BHVN - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Biohaven Ltd.|BHVN - Long-Term Debt to Equity|Current Liabilities to Capital Biohaven Corp|BHVN - Company Aggregate Debts|Debt to Book Capitalization Ratio Biohaven Corp|BHVN - Company Long-Term Debts|Short-Term Debt Volume Biohaven
Basic company analysis:Biohaven Ltd.
Finished products of Biohaven

To build a high-quality portfolio, it is essential to evaluate the issuer's aggregate resource potential, which is calculated here in reverse via return on assets (ROA) to eliminate reporting time lags. In the case of Biohaven Ltd. (BHVN), the current level of balance sheet assets reflects the scale of R&D investments and the scientific foundation, allowing the investor to correlate the value of intellectual property with the actual efficiency of the business.

Competitor analysis for Biohaven Ltd.

BIIB (biogen.com) - Total Business Assets|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|Harmony Corp (HRMY) - Company Assets|Company Total Assets Amylyx Pharmaceuticals|Aggregate Company Assets trevitherapeutics.com|PRAX (Praxis Precision Medicines, Inc.) - Company Total Assets|Company Total Asset Base AVXL (Anavex)|CBLL: Aggregate Company Assets|Company Assets Prothena PRTA|Company Total Assets Alector Therapeutics (ALEC)|ANNX - Aggregate Asset Value|OMER: Company Total Assets|Company Total Assets Neurogene Inc|Cumulative Company Assets AC Immune Corp|Aggregate Company Assets Voyager Corp|Neumora Therapeutics - Company Total Assets|Company Assets SCLX (scilexholding.com)|TVGN - Aggregate Company Assets|ACOG - Total Business Assets|Cumulative Company Assets Cognition Therapeutics, Inc. (CGTX)|IKT: Aggregate Asset Value|Cassava Sciences, Inc. (SAVA) - Aggregate Company Assets|Aggregate Company Assets Assertio|Coya Therapeutics Inc (COYA) - Cumulative Company Assets|Aggregate Business Assets VistaGen Therapeutics Inc|Company Total Assets Ovid Therapeutics Inc. OVID|Total Business Assets Acumen Pharmaceuticals, Inc ABOS|Cumulative Company Assets CRVO|Company Total Asset Base Alterity Therapeutics Ltd. ATHE|CLNN - Company Total Assets|PEPG - Aggregate Company Assets|Company Total Assets Jupiter Neurosciences JUNS|Aggregate Asset Value Relmada Corp|Cumulative Company Assets Annovis Bio, Inc.|Aggregate Company Assets GRCE|Aggregate Company Assets Firefly Neuroscience AIFF|Total Business Assets KLTO (anewmeds.com)|NRSN - Aggregate Company Assets|Total Business Assets Reviva Pharmaceuticals, Inc. RVPH|MTVA (MetaVia, Inc.) - Company Total Assets|neuraxis.com (NRXS) - Company Assets|HSDT: Cumulative Company Assets|PASG (Passage Bio) - Company Total Assets|NEUP - Aggregate Company Assets|Aggregate Asset Value NERV|Athira Pharma, Inc. - Aggregate Company Assets|Company Assets addextherapeutics.com (ADXN)|Company Total Assets Alzamend Neuro ALZN|Aggregate Company Assets Cyclerion Therapeutics Inc. CYCN|Company Total Assets PTIX (Protagenic)|KTTA: Company Total Asset Base|Aggregate Company Assets CRGT|avenuetx.com (ATXI) - Company Assets|BCLI - Company Total Assets|Aggregate Asset Value Cara Therapeutics Inc.|Company Total Assets CHRO|Company Total Assets eliemtx.com ELYM|Cumulative Company Assets Intra-Cellular Therapies, Inc. ITCI|Aggregate Company Assets longboardpharma.com LBPH|MRNS (Marinus Pharmaceuticals, Inc.) - Company Total Assets|NKGN: Company Assets|Aggregate Company Assets NeuroBo|Total Business Assets Sage Therapeutics Inc|SNPX - Cumulative Company Assets|Aggregate Asset Value TRVN|Aggregate Company Assets Vigil Neuroscience (VIGL)|Aggregate Company Assets anewmeds.com WENA|Cumulative Company Assets Cerevel (CERE)